What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Discover which index funds are top rated for retirement in 2024 and why they matter for your portfolio. Learn about performance, fees, and diversification.
25,164 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Amazon's AI hardware strategy could extend far beyond cloud services. This article explains how Trainium and Inferent...
A real-world tale shows how impersonation allegations can ripple into large Medicaid overpayments. Learn how to prote...
Starlink’s rumored mobile service could shake up how Americans connect on the go. This guide breaks down what that me...
The FCC is weighing a Know Your Customer style rule that would tie identity to every phone line. Privacy advocates wa...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...
Nuscale Power stock has drawn attention for a potential 195% upside from some analysts. This article breaks down what...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...
Apple accelerates its cash-return program with a fresh buyback authorization and a dividend bump, underscoring a disc...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...